U.S. Professional Services Stock News

Amcor (NYSE:AMCR) has been generating buzz after releasing its latest quarterly earnings along with news of a higher quarterly dividend. These updates usually spark increased investor attention, especially when profitability and shareholder returns are on display. See our latest analysis for Amcor. Amcor’s recent boost to its quarterly dividend and solid earnings have put it back on investors’ radar, especially as the company finalized a reverse stock split at its latest AGM. Despite these...

Arcellx (ACLX) just released its third quarter earnings, reporting a bigger net loss than last year. Investors are also watching for updates from upcoming clinical data presentations at a major hematology conference in December. See our latest analysis for Arcellx. Arcellx’s share price has seen some volatility lately, reflecting a tug-of-war between concerns about deeper quarterly losses and optimism ahead of December’s pivotal clinical data presentations. While the stock has delivered an...

Alpha Metallurgical Resources reported third-quarter 2025 results showing revenue of US$526.78 million and a net loss of US$5.52 million, while also reducing full-year shipment guidance for both metallurgical and thermal coal. Additionally, the company completed a significant share repurchase, retiring more than 42% of its shares since initiating the buyback in March 2022. We'll now explore how the reduction in 2025 shipment guidance could affect Alpha Metallurgical Resources' investment...

Piedmont Realty Trust recently completed a US$400 million senior notes offering at a 5.625% coupon due 2033, with proceeds earmarked to repurchase its higher-rate 9.250% senior notes due 2028 as part of a refinancing initiative. This refinancing transaction is expected to lower Piedmont's future interest expenses and enhance its capital structure flexibility as it continues to manage debt and pursue growth initiatives. We'll examine how this significant debt refinancing initiative influences...

Steven Madden (SHOO) just shared its latest quarterly numbers, revealing higher revenue compared to last year. However, profits took a step back. The company quickly followed up with upbeat expectations for the upcoming quarter and is projecting strong sales growth. See our latest analysis for Steven Madden. After a rocky start to the year, Steven Madden's momentum has picked up noticeably. The stock’s 41% share price gain over the past 90 days stands out, even though the 1-year total...

In recent days, Innospec Inc. reported third quarter 2025 results with net income of US$12.9 million on sales of US$441.9 million, declared a semi-annual dividend of US$0.87 per share to be paid in late November, and completed a significant share repurchase totaling 246,528 shares for US$22.2 million. The combination of a marked year-over-year earnings decline and concurrent shareholder return initiatives highlights Innospec's approach to balancing capital deployment with near-term...

In recent days, Abercrombie & Fitch announced a global partnership with luxury western retailer Kemo Sabe, launching a women’s collection featuring leather, denim, and accessories as part of Kemo Sabe’s first global retail venture. This collaboration underscores the increasing mainstream appeal of Western fashion and highlights Abercrombie & Fitch's commitment to leveraging noteworthy brand partnerships as part of its growth strategy. We'll now explore how this high-profile collaboration...

Ramaco Resources has just closed a $300 million fixed-income offering as it partners with Goldman Sachs on its Strategic Critical Minerals Terminal project. This move supports Ramaco’s ambitions to play a bigger role in the US critical minerals supply chain. See our latest analysis for Ramaco Resources. After surging earlier in the year, Ramaco Resources’ 1-year total shareholder return stands at an impressive 82.8%. This is despite a sharp 59.8% drop in the 1-month share price return...

Twist Bioscience (TWST) has experienced some ups and downs in recent weeks. The stock moved lower by about 6% over the past day and is down 2% in the past month. Investors are now sizing up whether recent momentum could shift as the broader biotech sector remains in focus. See our latest analysis for Twist Bioscience. Zooming out, Twist Bioscience’s year-to-date share price return of -34% shows momentum has faded after earlier gains, with the 1-year total shareholder return sitting at -23%...

Alvotech (NasdaqGM:ALVO) is in the spotlight after reporting a sharp turnaround to net income and securing a favorable UK High Court ruling on its Eylea biosimilar, AVT06. Both developments are drawing increased attention from market watchers. See our latest analysis for Alvotech. After a difficult stretch for shareholders, Alvotech’s recent net income turnaround and favorable UK court ruling may be helping sentiment recover, especially after sharp declines earlier this year. Even with a 9.1%...

VAST Data has announced an expanded collaboration with Google Cloud to enhance the accessibility of enterprise AI across hybrid cloud environments. This partnership introduces the VAST AI Operating System as a fully managed service on Google Cloud, enabling seamless connectivity between on-premises and cloud environments without the need for complex data migrations. The integration aims to simplify the deployment of AI workloads globally, allowing organizations to operate AI models across...

Even though BeOne Medicines AG's ( NASDAQ:ONC ) recent earnings release was robust, the market didn't seem to notice...

Investors weren't pleased with the recent soft earnings report from Hudson Technologies, Inc. ( NASDAQ:HDSN ). We did...

Haverty Furniture Companies, Inc. ( NYSE:HVT ) has announced that it will be increasing its periodic dividend on the...

It looks like Aflac Incorporated ( NYSE:AFL ) is about to go ex-dividend in the next 4 days. The ex-dividend date is...

Key Insights Provident Financial Holdings will host its Annual General Meeting on 20th of November Salary of US$511.5k...

ManpowerGroup Inc.'s ( NYSE:MAN ) investors are due to receive a payment of $0.72 per share on 15th of December. The...

Despite posting some strong earnings, the market for Telephone and Data Systems, Inc.'s ( NYSE:TDS ) stock hasn't moved...

Prosperity Bancshares, Inc. ( NYSE:PB ) has announced that it will be increasing its periodic dividend on the 2nd of...

Spectrum Brands Holdings recently reported fourth-quarter and full-year results, exceeding earnings expectations with adjusted earnings of $2.61 per share, despite a drop in net sales to US$733.5 million for the quarter and US$2.81 billion for the full year. Management highlighted strong cash flow performance, proactive supply chain management, and signaled readiness to pursue acquisitions, particularly within Global Pet Care and Home & Garden, as assets become available at improved...

Key Insights Reborn Coffee will host its Annual General Meeting on 20th of November Total pay for CEO Jay Kim includes...

Ever wondered whether PulteGroup is actually a bargain or if the price has already run away from you? We are diving into what the numbers and market signals are really saying about its value. Despite some ups and downs lately, PulteGroup's stock has climbed 10.0% year-to-date and delivered a massive 183.5% gain over the past three years. However, it is down 7.8% over the last twelve months. Recent headlines highlight strong U.S. homebuyer demand and ongoing supply constraints. Analysts point...

Align Technology, Inc. presented at the UBS Global Healthcare Conference on November 11, 2025, where CFO John F. Morici and IR Director Madelyn Valente discussed the company’s recent performance and innovations. An important highlight was the company’s strong third-quarter financial results, with revenue growth in Clear Aligners among younger patients and outperformance versus earnings expectations, following recent digital product launches. We’ll examine how Align’s surging Clear Aligner...

Henry Schein (HSIC) shares have caught the attention of investors after a steady climb over the past month, rising around 16%. Some are now weighing whether the stock’s recent momentum fits into a longer-term growth story. See our latest analysis for Henry Schein. Henry Schein’s strong 15.7% 1-month share price return signals building momentum, especially following a year where its total shareholder return reached 10.2%. That recent surge, along with improving fundamentals, suggests that...